Abstract:Background: Previous studies on pacemaker-associated heart failure (PaHF) have predominantly analyzed relatively small, single-center datasets, mainly focusing on incidence and predictors. However, the clinical implications of PaHF on mortality, particularly in relation to standard HF medications or upgrading to cardiac resynchronization therapy (CRT), has been underexplored. Methods: Utilizing nationwide real-world data from the Korean National Health Insurance Service database, we analyzed 32,216 patients undergoing permanent pacemaker (PPM) implantation without preexisting HF between 2008 and 2019. The incidence, predictors, and mortality risk of PaFH were evaluated. To address potential immortal-time bias due to the time-dependent occurrence of PaHF, the time from the PPM implantation to the first diagnosis of PaHF was analyzed as a time-dependent covariate. For patients with PaHF, a propensity score-matched analysis was conducted based on CRT-upgrade status to explore the effect of CRT-upgrade on the risk of all-cause mortality. Results: During the median 3.8-year follow-up period, PaHF and all-cause death occurred in 4170 (12.9%) and 6184 (19.2%) of the 32,216 PPM patients (42.3% male, mean age 70.6 years), respectively. PaHF development was closely associated with all-cause mortality, with a significantly higher mortality risk in the PaHF than in the non-PaHF group (hazard ratio [HR]=3.11, 95% confidence interval [CI]=2.93?3.32, P<0.001) after adjusting for immortal-time bias. The PaHF incidence and PaHF-associated mortality risk, although highest for the first six months post-PPM, did not disappear and increased again with follow-up time. In both the entire cohort (n=4170) and the propensity score-matched cohort (n=1685) of PaHF patients, CRT upgrade (HR=0.34, 95% CI=0.24?0.47, P<0.001), the use of beta-blockers (HR=0.75, 95% CI=0.61?0.93, P=0.010), and angiotensin receptor neprilysin inhibitor (ARNI) use (HR=0.28, 95% CI=0.14?0.54, P<0.001) were identified as potent protective factors against post-PaHF all-cause mortality. Conclusions: PaHF development independently predicted post-PPM mortality, while upgrading to CRT and the use of beta-blockers or ARNI were identified as favorable prognostic factors for post-PaHF overall survival. Therefore, for PaHF patients, an immediate change into CRT or conduction system pacing, may be required along with optimal HF medications owing to the ongoing mortality risk.

Risk factors and prognosis of pacemaker-identified new-onset atrial fibrillation

ANALYSIS OF PREDICTORS OF ATRIAL FIBRILLATION AFTER PACEMAKER IMPLANTATION

The Risk Factors of New-Onset Atrial Fibrillation after Pacemaker Implantation

New-onset Heart Failure after Permanent Right Ventricular Apical Pacing in Patients with Acquired High-Grade Atrioventricular Block and Normal Left Ventricular Function.

A retrospective study of atrial fibrillation after DDD pacemaker implantation

Atrial Fibrillation Burden Detected by Dual-Chamber Pacemakers As a Predictor for Cardiac Outcomes: A Retrospective Single-Center Cohort Study.

Correlation analysis of risk factors of atrial fibrillation after artificial cardiac pacemaker implantation

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation

Risks and long-term prognosis of new-onset heart failure after de novo permanent pacemaker implantation: nationwide cohort study

The incidence and risk factors of atrial high-rate episodes in patients with a dual-chamber pacemaker

Association Between Changes in Physical Activity and New-Onset Atrial Fibrillation After ICD/CRT-D Implantation

Implications of new-onset atrial fibrillation on in-hospital and long-term prognosis of patients with acute myocardial infarction: A report from the CBD bank study

Establishment and Verification of a Nomogram for Predicting the Probability of New-Onset Atrial Fibrillation after Dual-Chamber Pacemaker Implantation.

Multivariable analysis of incident ventricular tachycardia or ventricular fibrillation in patients with implantable cardioverter defibrillator

[Risk Factors for Heart Failure after Right Ventricular Apical Pacing].

Comparison of the outcome between patients with new-onset atrial fibrillation and patients retained sinus rhythm after cardiac resynchronization therapy

Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.

Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis

Incidence and predictors of new-onset atrial fibrillation in ST-elevation myocardial infarction: A single-center study

Prognostic significance of atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention

Rhythm Outcomes After Aortic Valve Surgery: Treatment And Evolution Of New-Onset Atrial Fibrillation